Regenerative Medical Technology reports positive Q2 operating income of $565.98K after a year-ago loss, with 64% gross margin.
Regenerative Medical Technology reported second-quarter revenue of $4.02 million, aligning with early indications. Gross profit rose to $2.58 million, reflecting a 64% margin, while operating income turned positive at $565.98 thousand versus a loss in the prior-year period.
The company ended the quarter with approximately $1.30 million in cash, providing liquidity for near-term operations. Prior-year results showed a net loss, making the current quarter’s profitability a notable improvement.
No immediate market reaction was disclosed in the release.